Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma - Bid, Hemant Kumar; Kibler, Aaron; Phelps, Doris A.; Manap, Sagymbek; Xiao, Linlin; Lin, Jiayuh; Capper, David; Oswald, Duane; Geier, Brian; DeWire, Mariko; Smith, Paul D.; Kurmasheva, Raushan T.; et al. (Clinical cancer research, 2013)
Gesehen am 25.11.2020